Dr. Mitchell H. Driesman, MD

Dr. Driesman practices at Northeast Medical Group, Inc. in Fairfield, Connecticut.

Dr. Driesman's NPI, 1578568382, was assigned on June 17, 2005. Dr. Driesman graduated from The Warren Alpert Medical School of Brown University in 1977. Dr. Driesman holds Connecticut license 023377.

Dr. Driesman's primary practice is Northeast Medical Group, Inc., at 1305 Post Rd, Fairfield, CT 06824 in Greater Bridgeport County. The practice phone is (203) 384-3975.

Dr. Driesman's primary practice is Northeast Medical Group, Inc. in Fairfield, Connecticut. Dr. Driesman is also affiliated with Yale New Haven Hospital. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Driesman to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Driesman practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Driesman's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Driesman is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Driesman is licensed in Connecticut.

Dmand AI lists cardiac catheterization among the conditions Dr. Driesman treats.

CMS data shows 2,679 Medicare services from Dr. Driesman across 13 procedure codes in 2024, for 707 Medicare patients. Medicare paid $128,559 for them. Every service was in an office.

CMS counts 707 Medicare patients who saw Dr. Driesman in 2024. The largest group is 75 to 84, with 311 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Driesman's median patient age at 74, with 46% women.

In 2024, Dr. Driesman wrote 7,078 Medicare Part D claims for 905 patients. 86% of them were for generic drugs. CMS names the drug for 6,748 of them, across 57 drugs with 11 or more claims each, at $1,356,978 in total drug cost. In 2023, CMS named 6,488 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Driesman for performance year 2024, reported through an alternative payment model (APM). Dr. Driesman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Driesman as offering telehealth.

Dmand AI links 3 papers to Dr. Driesman, published from 2008 to 2012. The most frequent topics are Angioplasty, Balloon, Coronary, Coronary Angiography and Sirolimus. Dr. Driesman's most frequent co-authors are Dominick Joseph Angiolillo, MD, Theodore A. Bass, MD and Hiram G. Bezerra, MD.

CMS Open Payments shows 272 general payments to Dr. Driesman from 29 drug and device companies from 2016 to 2019. Speaker and faculty fees make up the largest share, 62% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,023.

Dmand AI lists 5 awards for Dr. Driesman, most recently Greenwich Magazine in 2014.

Dr. Driesman graduated from The Warren Alpert Medical School of Brown University in 1977. Dr. Driesman is a member of ACC.

Dr. Driesman is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.